Xilong Scientific Co., Ltd. (SHE:002584)
China · Delayed Price · Currency is CNY 8.95
+0.16 (1.82%)
Oct 8, 2026, 12:24 PM CST
Xilong Scientific Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 5,238 | 5,390 | 4,208 | 5,729 | 4,056 | 6,203 | |
Market Cap Growth | -1.76% | 28.09% | -26.56% | 41.27% | -34.62% | 82.44% |
Enterprise Value | 6,138 | 5,818 | 4,978 | 6,486 | 4,244 | 6,342 |
Last Close Price | 8.79 | 9.21 | 7.19 | 9.72 | 6.88 | 10.52 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 130.12 | - | 68.11 | 171.80 | 45.54 | 33.16 |
Forward PE | - | 21.61 | 21.61 | 21.61 | 21.61 | 21.61 |
PS Ratio | 0.62 | 0.74 | 0.54 | 0.81 | 0.66 | 1.15 |
PB Ratio | 2.32 | 2.48 | 1.83 | 2.43 | 1.75 | 2.69 |
P/TBV Ratio | 2.52 | 2.71 | 1.99 | 2.64 | 1.86 | 3.47 |
P/FCF Ratio | - | - | 16.36 | - | - | 19.61 |
P/OCF Ratio | - | 77.70 | 13.93 | - | - | 16.63 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 0.73 | 0.79 | 0.64 | 0.92 | 0.69 | 1.18 |
EV/EBITDA Ratio | 28.13 | 31.46 | 23.79 | 41.79 | 32.40 | 40.25 |
EV/EBIT Ratio | 41.17 | 47.08 | 30.85 | 56.36 | 44.74 | 49.59 |
EV/FCF Ratio | - | - | 19.35 | - | - | 20.05 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.65 | 0.62 | 0.50 | 0.52 | 0.48 | 0.32 |
Debt / EBITDA Ratio | 6.83 | 7.09 | 5.22 | 7.40 | 8.02 | 4.57 |
Debt / FCF Ratio | - | - | 4.45 | - | - | 2.35 |
Net Debt / Equity Ratio | 0.40 | 0.30 | 0.24 | 0.28 | 0.06 | -0.04 |
Net Debt / EBITDA Ratio | 4.28 | 3.47 | 2.63 | 4.23 | 0.97 | -0.56 |
Net Debt / FCF Ratio | -1.89 | -20.88 | 2.14 | -1.31 | -0.25 | -0.28 |
Asset Turnover | 1.63 | 1.52 | 1.65 | 1.46 | 1.26 | 1.17 |
Inventory Turnover | 11.55 | 10.77 | 12.34 | 12.40 | 11.96 | 8.32 |
Quick Ratio | 1.07 | 1.17 | 1.17 | 1.10 | 1.16 | 1.06 |
Current Ratio | 1.47 | 1.56 | 1.65 | 1.61 | 1.57 | 1.55 |
Return on Equity (ROE) | 1.81% | -3.32% | 2.70% | 1.48% | 3.79% | 9.15% |
Return on Assets (ROA) | 1.76% | 1.60% | 2.13% | 1.48% | 1.21% | 1.73% |
Return on Invested Capital (ROIC) | 4.16% | 4.36% | 4.79% | 3.40% | 3.47% | 5.65% |
Return on Capital Employed (ROCE) | 5.50% | 4.70% | 5.90% | 4.30% | 3.60% | 5.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 0.76% | -1.40% | 1.47% | 0.58% | 2.20% | 3.02% |
FCF Yield | -9.18% | -0.57% | 6.11% | -8.73% | -12.69% | 5.10% |
Dividend Yield | - | - | 0.46% | 0.21% | - | - |
Payout Ratio | 121.82% | - | 134.80% | 149.86% | 48.48% | 27.62% |
Buyback Yield / Dilution | -5.79% | -3.40% | -1.04% | 6.39% | -11.09% | 6.02% |
Total Shareholder Return | -5.79% | -3.40% | -0.58% | 6.60% | -11.09% | 6.02% |